Browse

Set to go public via a reverse merger, Avere has licensed from a prolific Chinese drugmaker rights to a potential threat to medicines like Skyrizi and Icotyde.

Every year, the BIO International Convention brings together more than 20,000 leaders from across the global life sciences ecosystem.

AI still has the potential to do more than reduce corporate head counts. Watch out, Kendall Square.